Evidence map›Paper›PMID 23707980›Full record

ArticleNeuroscience2013

Tissue plasminogen activator contributes to morphine tolerance and induces mechanical allodynia via astrocytic IL-1β and ERK signaling in the spinal cord of mice.

T Berta, Y-C Liu, Z-Z Xu, R-R Ji

Abstract read
In one paragraph

Article in Neuroscience, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
3.5field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 50 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. UltramicronizedCurrent neuropharmacology · 2024
    Article
  5. Review
  6. Article
  7. Opioid Modulation of the Gut-Brain Axis in Opioid-Associated Comorbidities.Cold Spring Harbor perspectives in medicine · 2021
    Review
  8. Review
  9. Article
  10. Article
  11. Morphine tolerance is attenuated in germfree mice and reversed by probiotics, implicating the role of gut microbiome.Proceedings of the National Academy of Sciences of the United States of America · 2019
    Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 2 countries.

T BertaPain Signaling and Plasticity Laboratory, Department of Anesthesiology, Duke University Medical Center, Durham, NC 27710, USA.
Y-C Liu
Z-Z Xu
R-R Ji
Duke University Hospital · USBrigham and Women's Hospital · USHarvard University · US

Funding

Neuronal and glial interactions of neuropathic painR01DE017794 · NIDCR · DUKE UNIVERSITY · PI BUCHHEIT, THOMAS · 2006 to 2021
$6.6M
Resolvins, protectins, and chronic pain resolution.R01NS067686 · NINDS · DUKE UNIVERSITY · PI JI, RU-RONG, SERHAN, CHARLES NICHOLAS · 2009 to 2013
$2.8M
Hemichannels, Astrocytic Release, and Neuropathic PainR01DE022743 · NIDCR · DUKE UNIVERSITY · PI JI, RU-RONG, NEDERGAARD, MAIKEN · 2012 to 2016
$2.0M
Astroglial mechanisms for inflammatory painR01NS054932 · NINDS · BRIGHAM AND WOMEN'S HOSPITAL · PI JI, RU-RONG · 2007 to 2010
$1.4M
Resolution of chemotherapy-induced peripheral neuropathy by novel lipid mediatorR21NS082985 · NINDS · DUKE UNIVERSITY · PI XU, ZHEN-ZHONG · 2013 to 2014
$430k
NIDCR NIH HHS DE17794NIDCR NIH HHS DE22743NIDCR NIH HHS R01 DE017794NIDCR NIH HHS R01 DE022743NINDS NIH HHS NS67686NINDS NIH HHS NS82985NINDS NIH HHS R01 NS054932NINDS NIH HHS R01 NS067686NINDS NIH HHS R21 NS082985
6 · The paper itself

Abstract

Accumulating evidence indicates that activation of spinal cord astrocytes contributes importantly to nerve injury and inflammation-induced persistent pain and chronic opioid-induced antinociceptive tolerance. Phosphorylation of extracellular signal-regulated kinase (pERK) and induction of interleukin-1 beta (IL-1β) in spinal astrocytes have been implicated in astrocytes-mediated pain. Tissue plasminogen activator (tPA) is a serine protease that has been extensively used to treat stroke. We examined the potential involvement of tPA in chronic opioid-induced antinociceptive tolerance and activation of spinal astrocytes using tPA knockout (tPA(-/-)) mice and astrocyte cultures. tPA(-/-) mice exhibited unaltered nociceptive pain and morphine-induced acute analgesia. However, the antinociceptive tolerance, induced by chronic morphine (10mg/kg/day, s.c.), is abrogated in tPA(-/-) mice. Chronic morphine induces tPA expression in glial fibrillary acidic protein (GFAP)-expressing spinal cord astrocytes. Chronic morphine also increases IL-1β expression in GFAP-expressing astrocytes, which is abolished in tPA-deficient mice. In cultured astrocytes, morphine treatment increases tPA, IL-1β, and pERK expression, and the increased IL-1β and pERK expression is abolished in tPA-deficient astrocytes. tPA is also sufficient to induce IL-1β and pERK expression in astrocyte cultures. Intrathecal injection of tPA results in up-regulation of GFAP and pERK in spinal astrocytes but not up-regulation of ionized calcium binding adapter molecule 1 in spinal microglia. Finally, intrathecal tPA elicits persistent mechanical allodynia, which is inhibited by the astroglial toxin alpha-amino adipate and the MEK (ERK kinase) inhibitor U0126. Collectively, these data suggest an important role of tPA in regulating astrocytic signaling, pain hypersensitivity, and morphine tolerance.

Indexed as

AnimalsAstrocytesDrug ToleranceHyperalgesiaInjections, SpinalInterleukin-1betaMaleMAP Kinase Signaling SystemMiceMice, Inbred C57BLMice, KnockoutMorphinePhosphorylationSignal TransductionSpinal CordTissue Plasminogen ActivatorInterleukin-1betaMorphineTissue Plasminogen Activatoracute opioid analgesiachronic morphine exposuredorsal root gangliaDRGsERKERK kinaseextracellular signal-regulated kinaseextracellular signal-regulated kinase (ERK)FBSfetal bovine serumGAPDHGFAPglial fibrillary acidic proteinglyceraldehyde3-phosphate dehydrogenaseIBA-1IL-1βinterleukin-1 betainterleukin-1 beta (IL-1β)ionized calcium binding adapter molecule 1L-2-AAl-2-Aminoadipic acidlong-term potentiationLTPmatrix metalloprotease-2MEKMMP-2paw withdrawal latencypERKphosphoERKproteasePWLtissue plasminogen activatortPAtPA knockout micewild-typeWT

Identifiers

PMID23707980
PMCPMC3722295
OpenAlexW2095456655

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.